Pharmaceutical companies are increasingly under pressure to reduce the time it takes to discover new medicines. Recent advances in biophysical screening technology have made the detection of binding events associated with the smallest of fragments possible.
Often the biological target of interest has been determined but the identification of a suitable chemical starting point to optimize and deliver a drug candidate can often slow down the discovery process.
Watch this webinar to learn more about:
- Optimal fragment library design
- Biophysical screening and how it can be used to identify novel hits
- A cost-effective and expedient assay methodology
- How to speed up the timeline from target identification to confirmed hit from months (HTS), to weeks (fragment library)